Sintx Technologies (SINT) Free Cash Flow Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.28% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 9.63% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 22.80% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 29.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -27.72% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -0.27% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 77.20% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -20.37% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.32% |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 | 21.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.11% |
| Dec 31, 2025 | -0.38% |
| Sep 30, 2025 | 4.53% |
| Jun 30, 2025 | 6.09% |
| Mar 31, 2025 | 26.41% |
| Dec 31, 2024 | 23.95% |
| Sep 30, 2024 | 19.95% |
| Jun 30, 2024 | 2.10% |
| Mar 31, 2024 | 2.98% |
| Dec 31, 2023 | -12.06% |
| Sep 30, 2023 | -11.67% |
| Jun 30, 2023 | -27.00% |
| Mar 31, 2023 | -14.53% |
| Dec 31, 2022 | -14.73% |
| Sep 30, 2022 | -21.37% |
| Jun 30, 2022 | -21.21% |
| Mar 31, 2022 | -26.14% |
| Dec 31, 2021 | -25.49% |
| Sep 30, 2021 | -39.51% |
| Jun 30, 2021 | 9.62% |
| Mar 31, 2021 | -10.96% |
| Dec 31, 2020 | -51.37% |
| Sep 30, 2020 | 1.48% |
| Jun 30, 2020 | 4.16% |
| Mar 31, 2020 | -17.18% |
| Dec 31, 2019 | 10.20% |
| Sep 30, 2019 | 17.29% |
| Jun 30, 2019 | -17.59% |
| Mar 31, 2019 | 0.49% |
| Dec 31, 2018 | 12.65% |
| Sep 30, 2018 | -0.49% |
| Jun 30, 2018 | -14.24% |
| Mar 31, 2018 | 10.48% |
| Dec 31, 2017 | 35.31% |
| Sep 30, 2017 | 14.69% |
| Jun 30, 2017 | 36.91% |
| Mar 31, 2017 | 5.88% |
| Dec 31, 2016 | 25.55% |
| Sep 30, 2016 | -4.28% |
| Jun 30, 2016 | 30.73% |
| Mar 31, 2016 | -6.56% |